NASDAQ:AVTE
Delisted

Aerovate Therapeutics Stock Signals

etoro logo Buy AVTE
*Your capital is at risk
$2.68
+0 (+0%)
At Close: Jul 25, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Aerovate Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 61 days ( 0 %
Last Price $2.68 0 %
Performance History
7 Days
$2.68 $2.68
0%
30 Days
$2.68 $2.68
0%
12 Mos
$67.20 $2.68
-96.01%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $2.68 - $2.68
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jul 24, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low May 08, 2025 - 54 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium May 28, 2025 - 41 days
Short/Long MA 3 mos Sell Medium May 28, 2025 - 41 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 22.83
Signal Type Signal Value Importance Data
Trend - 12 mos -47.74 % Very High Width: 627.81 %
Pred. range - 12 mos N/A - $40.79 High -100.00 % - 1,421.96 %
Short MA 12 mos Sell Very High May 07, 2025 - 55 days
Long MA 12 mos Sell Very High Jun 12, 2025 - 30 days
Short/Long MA 12 mos Sell Very High Jun 12, 2025 - 30 days
Pivot Long Buy Low Apr 28, 2025 - 62 days
RSI Long Pivot Signal Buy Low May 19, 2025 - 47 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT AEROVATE THERAPEUTICS, INC.
Aerovate Therapeutics
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE